Enterprise Dynamic
All the subjects participating in this Phase I clinical trial of chlorogenic acid for injection were patients with high-grade malignant brain glioma refractory to international standard of care includ...
[View details]
At the end of 2017, the Company had been granted the patent applied in the United States, indicating that Jiuzhang Biotech had made important progress in the field of foreign intellectual property pro...
[View details]
The Second China BioMed Innovation and Investment Conference was held at the Suzhou Jinjihu International Conference Center on October 29, 2017, on which the Jiuzhang Biotech released the data of phas...
[View details]
On July 12, 2017, the Company received the Patent Authorization issued by the State Intellectual Property Bureau, which showed that the Company has obtained one more granted invention patent in treati...
[View details]
